You are here: Industry Insights > COVID-19 vaccine

News List

GSK, Sanofi launch late-stage COVID-19 vaccine study pharmatimes
May 27, 2021
GlaxoSmithKline (GSK) and Sanofi have begun enrolling participants into a Phase III clinical study of their adjuvanted recombinant-protein COVID-19 vaccine candidate.
India might get Moderna’s single-dose COVID-19 vaccine next year; Pfizer offers five crore shots in 2021 expresspharma
May 27, 2021
While Moderna has conveyed to Indian authorities that it does not have surplus vaccines to share in 2021, there are limited prospects of Johnson & Johnson exporting its jabs from the US to other countries in the near future.
Dyadic Collaborates with Syngene to Develop Covid-19 Vaccine Candidate contractpharma
May 27, 2021
Dyadic International Inc. a global biotechnology company, has entered into a collaboration with Syngene International Limited, an integrated research, development, and manufacturing services company, to develop a COVID-19 vaccine candidate that can ...
Moderna COVID-19 Vaccine Highly Effective in Children 12 and Older drugs
May 26, 2021
The Moderna COVID-19 vaccine fully protects children aged 12 to 17 years, the company announced Tuesday.
Bharat Biotech may begin paediatric trials of COVAXIN in June expresspharma
May 26, 2021
Bharath Biotech has received permission to carry out paediatric trials of the vaccine and it may commence trials from June 1.
Novavax to Present at International Society for Vaccines Virtual Congress COVID-19 Vaccine Update firstwordpharma
May 25, 2021
NVAX today announced that Gregory M. Glenn, M.D., will present on NVX-CoV2373, the company's recombinant nanoparticle COVID-19 vaccine candidate, during the 2021 International Society for Vaccines Virtual Congress 6thCOVID-19 Vaccine Update.
60 million doses of COVID-19 vaccine administered in UK worldpharmanews
May 25, 2021
Health services across the UK have now administered a total of around 60.6 million vaccines since 8 December, including around 37.9 million people with their first dose (72%) and 22.6 million with both doses (43%), ensuring they have the strongest ...
CanSinoBIO Receives European GMP Certification for its COVID-19 Vaccine Convidecia™ prnewswire
May 25, 2021
CanSinoBIO today announced that its Recombinant Novel Coronavirus Vaccine, has been granted a Good Manufacturing Practice ("GMP") certificate by the Hungarian National Institute of Pharmacy and Nutrition (OGYÉI).
Cadila Healthcare to make around 30 million doses of COVID-19 vaccine a month: Managing Director expresspharma
May 25, 2021
Cadila Healthcare is aiming to triple the monthly production of COVID-19 vaccine candidate to as many as 30 million doses, its MD said.
New Moderna agreement will double vaccine drug substance production at Visp cphi-online
May 24, 2021
Three additional drug substance manufacturing lines will be added to existing ones at Swiss site and are expected to be operational in early 2022

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page